In compliance with current regulations, let us know which audience you belong to:
03 | 02 | 2022
—clinical
Light Modulation® LLLT: Superior Tech
We’re proud to announce our Light Modulation® LLLT technology has recently been studied in a piece of research that compared it directly against IPL tech.
The study, published on Cornea, the Journal of Cornea and External Disease, by Giuseppe Giannaccare (MD, PhD) et al., has confirmed the efficacy of LM® LLLT, proving also its superior performance against IPL.
The purpose of the study was to evaluate and compare the safety and efficacy of low-level light therapy (LLLT) and intense pulsed light (IPL) for the treatment of meibomian gland dysfunction (MGD).
Directly citing the conclusions of the research paper:
Both LLLT and IPL were safe and effective in improving ocular discomfort symptoms in patients with MGD; however, the former determined a greater improvement in symptoms and an improvement of tear volume.
SOURCE:
Giannaccare, G., Pellegrini, M., Scalzo, G. C., Borselli, M., Ceravolo, D., & Scorcia, V. (2022). Low-Level Light Therapy Versus Intense Pulsed Light for the Treatment of Meibomian Gland Dysfunction: Preliminary Results From a Prospective Randomized Comparative Study. Cornea. ISO 690